Schonfeld Strategic Advisors LLC Tango Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $15.4 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$6.52 - $12.01 $98,491 - $181,423
15,106 Added 36.58%
56,400 $558,000
Q3 2023

Nov 14, 2023
BUY
$2.93 - $11.26 $120,991 - $464,970
41,294 New
41,294 $464,000
Q3 2022

Nov 14, 2022
BUY
$3.25 - $5.46 $52,000 - $87,360
16,000 New
16,000 $58,000

Others Institutions Holding TNGX

# of Institutions
135
Shares Held
92.6M
Call Options Held
3.1K
Put Options Held
1.5K
View Full List

About Tango Therapeutics, Inc.

TNGX Quotes by TradingView
  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $218M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email